Burkina Faso

in page functions
[French]
Burkina Faso
Total population (2017) 19,173,317
Birth cohort (2017) 741,830
Surviving Infants (surviving to 1 year per year, 2017) 698,043
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 61/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 89/1000
World Bank Index, IDA (2015) 3.61
Gross Nation Income (per capita US$, 2015) 640
Co-financing group (2017) Initial self-financing
No. of districts/territories (2015) 63

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Burkina Faso

Type of support

Approvals

2001-2021 (US$)
(29 Jun 2017)

Commitments

2001-2021 (US$)
(29 Jun 2017)

Disbursements

2000-2017 (US$)
(29 Jun 2017)

% Disbursed

(29 Jun 2017)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $194,661,178 $264,697,678 $186,901,632
Cash Support (CASHSUPP) $145,000 $170,000 $145,000 100%
Health system strengthening (HSS 1) $4,978,500 $4,978,500 $4,978,500 100%
Health system strengthening (HSS 2) $4,511,558 $4,511,558 $4,511,558 100%
Health system strengthening (HSS 3) $5,040,000 $11,760,000
HPV Demo (NVS) $191,000 $191,000 $190,622 100%
Immunisation services support (ISS) $9,768,940 $9,768,940 $9,768,940 100%
Injection Safety Devices (NVS) $323,000 $1,165,500 $403,204 125%
Injection safety support (INS) $931,560 $931,560 $931,560 100%
IPV (NVS) $81,602 $81,602 $66,679 82%
Measles (NVS) $916,650 $1,177,150 $918,344 100%
Measles-Rubella (NVS) $6,000,965 $6,000,965 $6,000,965 100%
Meningitis A (NVS) $574,000 $1,996,500 $491,371 86%
Meningitis A - mini catch-up campaign (NVS) $3,219,000 $3,219,000 $3,134,671 97%
Meningitis A - mini catch-up op.costs (OPC) $2,571,802 $2,571,802 $2,571,802 100%
MR - Operational costs (OPC) $5,183,000 $5,183,000 $5,183,000 100%
Penta (NVS) $63,900,656 $71,418,156 $62,763,061 98%
Pneumo (NVS) $46,251,288 $73,321,288 $50,317,238 109%
Rotavirus (NVS) $36,514,163 $62,692,663 $30,966,623 85%
Vaccine Introduction Grant (VIG) $3,558,494 $3,558,494 $3,558,494 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Burkina Faso DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 91%
M:F sex ratio at birth (2017) 1.05
Household survey: DTP3 coverage for male (2009) 90.30%
Household survey: DTP3 coverage for female (2009) 88.80%
Household survey: Last DTP3 survey (2009) 90%
% districts achieving > 80% DTP3 coverage (2015) 100%
% districts achieving < 50% DTP3 coverage (2015) 0%
MCV WHO/UNICEF estimates (2016) 88%

Breakdown of support

Non-vaccine support Vaccine support
17% 83%
$31,648,854 $155,252,778

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Burkina Faso

25 April 2017

Central African Republic, a mother and her two children.

Central African Republic: mother spreads word about meningitis A vaccine

Izimili Raude knows that her community must rely on vaccines, not miracles, to spare children from a deadly disease.

27 July 2016

First Sudanese child to receive Meningitis A vaccine as part of routine immunization.

Sudan: first to introduce life-saving meningitis A vaccine into routine immunization

Children in Sudan are set to become the first in the Meningitis belt to benefit from the introduction of Meningitis A vaccine into a routine immunization programme.

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

close icon

modal window here